Evidence map›Paper›PMID 30666449›Full record

ArticleEuropean radiology2019

Integrated analysis of

Antoine Girard, Mathieu Rouanne, Sarah Taconet, Camélia Radulescu, Yann Neuzillet, Astrid Girma, Aurélie Beaufrere, Thierry Lebret, Elise Le Stanc, Jean-François Grellier

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 68 citations in OpenAlex.

  1. Diagnostic accuracy ofFrontiers in medicine · 2026
    Article
  2. European journal of nuclear medicine and molecular imaging · 2025
    Article
  3. Diagnostic efficacy of [Discover oncology · 2025
    Article
  4. Review
  5. Review
  6. FDG-PET/CT for lymph node staging prior to radical cystectomy.European journal of hybrid imaging · 2023
    Article
  7. Review
  8. Article
  9. PET Imaging in Bladder Cancer: An Update and Future Direction.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Role of PET/CT in muscle-invasive bladder cancer.Translational andrology and urology · 2020
    Review
  16. The Role of Imaging in Bladder Cancer Diagnosis and Staging.Diagnostics (Basel, Switzerland) · 2020
    Review
  17. Article
  18. Review
  19. Comment on: Relationship between the expression of PD-1/PD-L1 andEuropean journal of nuclear medicine and molecular imaging · 2019
    Article
  20. The management of muscle-invasive bladder Cancer is still a significant challenge in the clinical practice.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Antoine GirardDepartment of Nuclear Medicine, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, 40, Rue Worth, 92150, Suresnes, France. a.girard@rennes.unicancer.fr.ORCID http://orcid.org/0000-0002-9472-9980
Mathieu RouanneDepartment of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Sarah TaconetDepartment of Pathology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Camélia RadulescuDepartment of Pathology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Yann NeuzilletDepartment of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Astrid GirmaDepartment of Nuclear Medicine, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, 40, Rue Worth, 92150, Suresnes, France.
Aurélie BeaufrereDepartment of Pathology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Thierry LebretDepartment of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Elise Le StancDepartment of Nuclear Medicine, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, 40, Rue Worth, 92150, Suresnes, France.
Jean-François GrellierDepartment of Nuclear Medicine, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, 40, Rue Worth, 92150, Suresnes, France.
Université de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPreoperative

methodsFrom May 2015 to May 2017, we prospectively included patients with urothelial bladder cancer who underwent radical cystectomy with extended pelvic LN dissection. All patients underwent preoperative

resultsIn total, 1012 LNs were identified in 61 patients with clinically localized invasive bladder cancer who underwent radical cystectomy and extended pelvic LN dissection. Loco-regional involvement of 24 LN areas was confirmed in 17 patients. In per area analysis, diagnostic accuracy of PET/CT and CT alone were respectively 84% and 78% (p = 0.039). On patient-based analysis, combined PET/CT correctly classified pelvic LN status in 5/61 (+ 8%) additional patients using optimal thresholds compared to CT alone, with accuracies of 82% and 74%, respectively (p = 0.13).

conclusionCombining SUV KEY POINTS: • Combining metabolical and morphological features using

Indexed as

Neoplasm StagingAgedAged, 80 and overCystectomyFemaleFluorodeoxyglucose F18HumansLymphatic MetastasisLymph NodesMaleMiddle AgedPelvisPositron Emission Tomography Computed TomographyPreoperative PeriodRadiopharmaceuticalsUrinary Bladder NeoplasmsFluorodeoxyglucose F18RadiopharmaceuticalsLymph nodesNeoplasm stagingPositron emission tomography computed tomographyUrinary bladder neoplasms

Identifiers

PMID30666449
OpenAlexW2917363484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.